Familial aspects of narcolepsy-cataplexy in the Czech Republic

Sleep. 1997 Nov;20(11):1021-6. doi: 10.1093/sleep/20.11.1021.

Abstract

A group of 153 probands with narcolepsy included 38 subjects (24.8%) with a familial incidence of excessive daytime sleepiness (EDS). In 15 cases (9.8%), at least one additional family member suffered from narcolepsy-cataplexy; only EDS was present in the remaining 23 cases (15.0%). One thousand eighty-two relatives were evaluated. The percentage of first degree relatives affected with narcolepsy-cataplexy was 2.28% (1.20% if only clinically confirmed cases were accounted); the adequate value for second degree relatives was 1.49%. The occurrence of EDS exceeded these values several times (4.28% in first degree relatives, 6.57% in second degree relatives). The vertical mode of transmission was found in most families. Human leukocyte antigen (HLA) typing was performed in six families with multiple-case incidence of narcolepsy. Forty-one blood samples were analyzed (12 patients with narcolepsy, 7 with only EDS, 2 with sleep apnea syndrome, and 20 healthy relatives). HLA DR2+ and DQB1*0602+ were found in only 8 out of 12 narcoleptic patients with cataplexy and in six out of seven patients with isolated attacks of sleepiness. These findings support the hypothesis that there is a common genetic basis for narcolepsy associated with cataplexy and "monosymptomatic" forms of narcolepsy and suggest the existence of non-major histocompatibility complex (MHC) susceptibility factors for narcolepsy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Cataplexy / etiology
  • Cataplexy / genetics*
  • Cataplexy / immunology
  • Czech Republic
  • Female
  • Genotype
  • HLA-DQ Antigens / immunology
  • HLA-DR Antigens / immunology
  • Humans
  • Infectious Disease Transmission, Vertical
  • Male
  • Middle Aged
  • Narcolepsy / complications
  • Narcolepsy / genetics*
  • Narcolepsy / immunology
  • Pedigree

Substances

  • HLA-DQ Antigens
  • HLA-DR Antigens